Actionable news
0
All posts from Actionable news
Actionable news in ATRA: ATARA BIOTHERAPEUTICS INC,

Atara Biotherapeutics, Inc.'s Chief Executive Officer just disposed of 1,300 shares

Isaac E. Ciechanover, Atara Biotherapeutics, Inc.'s Chief Executive Officer and a director of the company, recently disposed of 1,300 shares of the company. The disposals took place at prices ranging from $20.12 to $20.15 per share, on dates ranging from April 25 to April 26, 2016. Ciechanover still owns 1,211,656 shares of the company. Ciechanover operates out of South San Francisco, CA. Some additional info was provided as follows:

Transaction pursuant to Rule 10b5-1 Plan adopted December 12, 2014. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $20.03 to $20.29. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shar es sold at each price within the range. Shares are held by the Isaac E. Ciechanover and Allison M. Ciechanover Family Trust dated 8/8/08, of which the Reporting Person is a trustee. Sheld are held by the Ciechanover Family GRAT, of which the Reporting Person is a trustee. Sheld are held by the The Ciechanover 2015 GRAT, of which the Reporting Person is a trustee.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Atara Biotherapeutics, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Atara Biotherapeutics, Inc.'s Chief Executive Officer just disposed of 1,190 shares - April 4, 2016